• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大鼠对重组人白细胞介素-1β和一种三肽白细胞介素-1β拮抗剂的食物摄入量及体温反应

Food intake and body temperature responses of rats to recombinant human interleukin-1 beta and a tripeptide interleukin-1 beta antagonist.

作者信息

McLaughlin C L, Rogan G J, Tou J, Baile C A, Joy W D

机构信息

Animal Science Division, Monsanto Company, St. Louis, MO 63198.

出版信息

Physiol Behav. 1992 Dec;52(6):1155-60. doi: 10.1016/0031-9384(92)90475-h.

DOI:10.1016/0031-9384(92)90475-h
PMID:1484875
Abstract

Food intake and body temperature are two of many factors affected by IL-1 beta, a cytokine which is produced in response to tissue injury and inflammatory processes. In the present experiment, a tripeptide IL-1 beta antagonist which blocked IL-1 beta-induced hyperalgesia was tested for the ability to block IL-1 beta-induced effects on food intake and body temperature. Food intake was decreased 4-22 h after intraperitoneal (IP) administration of 1.25, 1.88, or 2.50 micrograms IL-1 beta/rat, and 0-22 h food intake was decreased by 1.88 and 2.50 micrograms IL-1 beta/rat. The effect of 1.25 micrograms IL-1 beta/rat on food intake measured 4 and 22 h after (IP) injection was blocked by coadministration of 5 mg tripeptide IL-1 beta antagonist. However, 25 mg tripeptide IL-1 beta antagonist/rat plus 1.25 micrograms IL-1 beta/rat decreased 0-22 h food intake more than IL-1 beta alone. Administration (IP) of 1.25 micrograms IL-1 beta/rat increased body temperature 1 degrees C 4 h later, and 5 and 25 mg tripeptide IL-1 beta antagonist/rat blocked this increase. Although food intake remained decreased after IL-1 beta administration alone or with 25 mg tripeptide IL-1 beta antagonist/rat for 22 h, body temperature returned to normal under these conditions. Thus, a tripeptide IL-1 beta antagonist shown to block IL-1 beta-induced hyperalgesia also blocked food intake and body temperature responses to IL-1 beta, although the effective doses of IL-1 beta and the tripeptide IL-1 beta antagonist differ by 4,000-fold when both are administered peripherally.

摘要

食物摄入量和体温是受白细胞介素-1β(IL-1β)影响的众多因素中的两个,IL-1β是一种在组织损伤和炎症过程中产生的细胞因子。在本实验中,测试了一种能阻断IL-1β诱导的痛觉过敏的三肽IL-1β拮抗剂对阻断IL-1β诱导的食物摄入量和体温影响的能力。腹腔注射(IP)1.25、1.88或2.50微克IL-1β/大鼠后4至22小时食物摄入量减少,而0至22小时食物摄入量在注射1.88和2.50微克IL-1β/大鼠时减少。腹腔注射(IP)1.25微克IL-1β/大鼠后4小时和22小时测量的食物摄入量效应,在同时给予5毫克三肽IL-1β拮抗剂时被阻断。然而,25毫克三肽IL-1β拮抗剂/大鼠加1.25微克IL-1β/大鼠使0至22小时食物摄入量的减少比单独使用IL-1β时更大。腹腔注射(IP)1.25微克IL-1β/大鼠4小时后体温升高1摄氏度,而5毫克和25毫克三肽IL-1β拮抗剂/大鼠可阻断这种升高。尽管单独给予IL-1β或与25毫克三肽IL-1β拮抗剂/大鼠一起给药22小时后食物摄入量仍保持减少,但在这些条件下体温恢复正常。因此,一种已证明能阻断IL-1β诱导的痛觉过敏的三肽IL-1β拮抗剂也阻断了对IL-1β的食物摄入量和体温反应,尽管当两者都经外周给药时,IL-1β和三肽IL-1β拮抗剂的有效剂量相差4000倍。

相似文献

1
Food intake and body temperature responses of rats to recombinant human interleukin-1 beta and a tripeptide interleukin-1 beta antagonist.大鼠对重组人白细胞介素-1β和一种三肽白细胞介素-1β拮抗剂的食物摄入量及体温反应
Physiol Behav. 1992 Dec;52(6):1155-60. doi: 10.1016/0031-9384(92)90475-h.
2
Continuous infusion of interleukin-1 beta induces a nonthyroidal illness syndrome in the rat.持续输注白细胞介素-1β可诱导大鼠出现非甲状腺疾病综合征。
Endocrinology. 1992 Nov;131(5):2139-46. doi: 10.1210/endo.131.5.1425414.
3
Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1 beta.脑室内注射特定的白细胞介素-1受体拮抗剂可阻断白细胞介素-1β诱导的食物和水摄入抑制。
Physiol Behav. 1992 Jun;51(6):1277-9. doi: 10.1016/0031-9384(92)90321-r.
4
Human recombinant interleukin-1 receptor antagonist prevents adrenocorticotropin, but not interleukin-6 responses to bacterial endotoxin in rats.人重组白细胞介素-1受体拮抗剂可抑制大鼠体内促肾上腺皮质激素的产生,但不能抑制白细胞介素-6对细菌内毒素的反应。
Endocrinology. 1993 Dec;133(6):2461-8. doi: 10.1210/endo.133.6.8243265.
5
Chronic effects of interleukin-1 beta on fever, oxygen consumption and food intake in the rat.白细胞介素-1β对大鼠发热、耗氧量及食物摄入量的慢性影响。
Horm Metab Res. 1993 Apr;25(4):222-7. doi: 10.1055/s-2007-1002081.
6
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.不同的受体机制介导白细胞介素1的致热和行为效应。
Proc Natl Acad Sci U S A. 1992 Oct 1;89(19):9117-20. doi: 10.1073/pnas.89.19.9117.
7
Central administration of ibuprofen failed to block the anorexia induced by interleukin-1.
Eur J Pharmacol. 1991 Mar 26;195(2):281-4. doi: 10.1016/0014-2999(91)90547-4.
8
Synergism between IL-1 beta and TNF-alpha on the activity of the pituitary-adrenal axis and on food intake of rats.白细胞介素-1β与肿瘤坏死因子-α对大鼠垂体-肾上腺轴活性及食物摄入量的协同作用。
Am J Physiol. 1995 Apr;268(4 Pt 1):E551-7. doi: 10.1152/ajpendo.1995.268.4.E551.
9
Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat.通过向大鼠腹内侧下丘脑微量注射白细胞介素-1β诱导食物和水摄入量减少。
Physiol Behav. 1994 Nov;56(5):1031-6. doi: 10.1016/0031-9384(94)90339-5.
10
Differential effects of IL-1ra on sickness behavior and weight loss induced by IL-1 in rats.
Brain Res. 1995 Apr 17;677(1):171-6. doi: 10.1016/0006-8993(95)00194-u.

引用本文的文献

1
Pentoxifylline treatment in patients with cancer cachexia: A double-blind, randomized, placebo-controlled clinical trial.己酮可可碱治疗癌症恶病质患者:一项双盲、随机、安慰剂对照临床试验。
Adv Biomed Res. 2016 Mar 22;5:60. doi: 10.4103/2277-9175.179182. eCollection 2016.
2
Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task.白细胞介素 1-β的与努力相关的动机效应:与同时进行的固定比率 5/食物选择任务相关的研究。
Psychopharmacology (Berl). 2014 Feb;231(4):727-36. doi: 10.1007/s00213-013-3285-4. Epub 2013 Oct 18.
3
Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia.
332 例癌症恶病质患者 5 种不同治疗组的随机 III 期临床试验。
Oncologist. 2010;15(2):200-11. doi: 10.1634/theoncologist.2009-0153. Epub 2010 Feb 15.
4
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia.COX-2 抑制剂塞来昔布治疗癌症恶病质患者的疗效和安全性的 II 期非随机研究。
J Mol Med (Berl). 2010 Jan;88(1):85-92. doi: 10.1007/s00109-009-0547-z. Epub 2009 Oct 3.
5
Managing cancer-related anorexia/cachexia.应对癌症相关的厌食/恶病质。
Drugs. 2001;61(4):499-514. doi: 10.2165/00003495-200161040-00004.